Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial

Background: The phase 4, METABOLIK trial demonstrated that changes in metabolic parameters with darunavir with low-dose ritonavir (DRV/r) were comparable to those observed with atazanavir with low-dose ritonavir (ATV/r). A comprehensive assessment of the effects of these agents on insulin sensitivit...

Descripción completa

Detalles Bibliográficos
Autores principales: Overton, Edgar Turner, Tebas, Pablo, Coate, Bruce, Ryan, Robert, Perniciaro, Amy, Dayaram, Yaswant K., De La Rosa, Guy, Baugh, Bryan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020348/
https://www.ncbi.nlm.nih.gov/pubmed/26917112
http://dx.doi.org/10.1080/15284336.2016.1141468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020348/
https://www.ncbi.nlm.nih.gov/pubmed/26917112
http://dx.doi.org/10.1080/15284336.2016.1141468

Ejemplares similares